Dreyer Scott
EVP & Chief Commercial Officer
Dreyer Scott has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Dreyer Scott is listed as EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC. Inside the rolling window, Dreyer Scott reported no open-market purchases and 2 open-market sales totaling $2.9M in COLL. The largest disclosed transaction in the window is a sale of 49,976 COLL shares on Mar 3, 2026, worth $2.0M.
Companies traded
Other insiders at COLL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dreyer Scott made?
Dreyer Scott has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Dreyer Scott trade?
Dreyer Scott has filed SEC Form 4 disclosures for 1 company, including COLL.
When was Dreyer Scott's most recent SEC Form 4 filing?
Dreyer Scott's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Dreyer Scott's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dreyer Scott is listed as EVP & Chief Commercial Officer.
What is Dreyer Scott's total buy and sell value in the current window?
Inside the rolling retention window, Dreyer Scott bought $0 and sold $2.9M based on SEC Form 4 filings.
What was Dreyer Scott's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 49,976 COLL shares on 2026-03-03, worth $2.0M, per SEC Form 4 filings.